Yu-Hsin Lin reports stock transactions at Belite Bio
By AlphaYouPublished Form 4
Lin Yu-Hsin
Reporting filer
Yu-Hsin Lin reports stock transactions, not an open-market purchase or sale, in Belite Bio, Inc. Form 4 filed Oct 31, 2026 lists 1 entry.
- Disclosed
- Oct 31, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Ordinary Share | Lin Yu-Hsin | 2026-10-29 | J | Other (see filing) | 5000 | 0 | 187,949 | 2 days | Filed terms
|
Ordinary Share
- Owner
- Lin Yu-Hsin
- Date
- 2026-10-29
- Code
- J
- Action
- Other (see filing)
- Quantity
- 5000
- Price
- 0
- Following holdings
- 187,949
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Ordinary Share
- transaction Date: 2026-10-29
- transaction Form Type: 4
- transaction Code: J
- equity Swap Involved: false
- id: F1
- transaction Shares: 5000
- id: F1
- transaction Price Per Share: 0
- id: F1
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 187949
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Lin Yu-Hsin: Chief Executive Officer, Director.
- F1: On September 15, 2025, the reporting person was granted an award of restricted stock units ("RSUs") which shall vest upon satisfaction of several performance criteria. Certain of these performance criteria were met on 10/29/2026, resulting in vesting of the RSUs as to 5,000 ordinary shares.
Original sources
Prepared automatically from public filing data. Report a correction.